~~<i id='D0C249BCAF'><strike id='D0C249BCAF'><tt id='D0C249BCAF'><pre id='D0C249BCAF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：leisure time 2025-08-21 06:56:05 - browse：876

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： What do new weight loss drugs mean for bariatric surgery?

entertainment

focus

entertainment

Medicarelaidoutinthegreatestdetailyethowitwillchoosewhichdrugpricesitwillnegotiateinitsbrand-newprog

WSS

Complete sequence of Y chromosome published for first time

FDA warns medical device makers about rise in fabricated data

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Measles policy set amid Florida outbreak alarms vaccine proponents

How to make Best Hospitals ratings actually useful for patients

Obamacare plans could cover weight loss drugs

Wikipedia

Wikipedia

entertainment

Moonlake's readout produced a cash windfall. Risks remain

WATCH: Why do our ears pop?

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

United colonoscopy coverage change 'may cost lives,' doctors say

NYU Langone launches private ChatGPT for its health care data

Guidelines to prevent youth baseball injuries need more muscle

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

How to make Best Hospitals ratings actually useful for patients

CDC advisory panel says seniors 'may' get RSV vaccine

New study raises questions about niacin and heart health

Drug firms test therapies to halt Alzheimer’s before symptoms arise

What do new weight loss drugs mean for bariatric surgery?

FDA warns medical device makers about rise in fabricated data

focus

focus

focus

entertainment